Age-Associated TET2 Mutations: Common Drivers of Myeloid Dysfunction, Cancer and Cardiovascular Disease
出版年份 2020 全文链接
标题
Age-Associated TET2 Mutations: Common Drivers of Myeloid Dysfunction, Cancer and Cardiovascular Disease
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 2, Pages 626
出版商
MDPI AG
发表日期
2020-01-20
DOI
10.3390/ijms21020626
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis
- (2019) Paul M Ridker et al. EUROPEAN HEART JOURNAL
- Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation
- (2019) Silvia Mas-Peiro et al. EUROPEAN HEART JOURNAL
- Genetic IL-6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis
- (2019) Alexander G. Bick et al. CIRCULATION
- Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
- (2019) Andrew B. Das et al. Blood Cancer Journal
- Familial myeloid malignancies with germline TET2 mutation
- (2019) Nicolas Duployez et al. LEUKEMIA
- An inflammatory environment containing TNFα favors Tet2 -mutant clonal hematopoiesis
- (2018) Samuel O. Abegunde et al. EXPERIMENTAL HEMATOLOGY
- Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
- (2018) Soichi Sano et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis
- (2018) Christopher Maximilian Arends et al. LEUKEMIA
- The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia
- (2018) Huihui Zhao et al. LEUKEMIA RESEARCH
- Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host
- (2018) Marlies Meisel et al. NATURE
- Somatic mutations precede acute myeloid leukemia years before diagnosis
- (2018) Pinkal Desai et al. NATURE MEDICINE
- The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
- (2018) Tiziano Barbui et al. Blood Cancer Journal
- Dynamics of DNMT3A mutation and prognostic relevance in patients with primary myelodysplastic syndrome
- (2018) Ming-En Lin et al. Clinical Epigenetics
- Prediction of acute myeloid leukaemia risk in healthy individuals
- (2018) Sagi Abelson et al. NATURE
- Population dynamics of normal human blood inferred from somatic mutations
- (2018) Henry Lee-Six et al. NATURE
- Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis
- (2018) Zhigang Cai et al. Cell Stem Cell
- Somatic Mutations Reveal Lineage Relationships and Age-Related Mutagenesis in Human Hematopoiesis
- (2018) Fernando G. Osorio et al. Cell Reports
- Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure
- (2018) Lena Dorsheimer et al. JAMA Cardiology
- Tet2 restrains inflammatory gene expression in macrophages
- (2017) Alyssa H. Cull et al. EXPERIMENTAL HEMATOLOGY
- Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117
- (2017) Mikkael A. Sekeres et al. JOURNAL OF CLINICAL ONCOLOGY
- Success in bone marrow failure? Novel therapeutic directions based on the immune environment of myelodysplastic syndromes
- (2017) Alyssa H. Cull et al. JOURNAL OF LEUKOCYTE BIOLOGY
- NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018
- (2017) Ruben A. Mesa et al. Journal of the National Comprehensive Cancer Network
- CHIP, ICUS, CCUS and other four-letter words
- (2017) R Bejar LEUKEMIA
- Ascorbate regulates haematopoietic stem cell function and leukaemogenesis
- (2017) Michalis Agathocleous et al. NATURE
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
- (2017) José J. Fuster et al. SCIENCE
- Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts
- (2017) Iván Martín et al. Blood Cancer Journal
- DOT1L as a therapeutic target for the treatment of DNMT3A -mutant acute myeloid leukemia
- (2016) Rachel E. Rau et al. BLOOD
- Uncompromised 10-year survival of oldest old carrying somatic mutations in DNMT3A and TET2
- (2016) E. B. van den Akker et al. BLOOD
- The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
- (2016) A. A. Basiorka et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Mesenchymal Inflammation Drives Genotoxic Stress in Hematopoietic Stem Cells and Predicts Disease Evolution in Human Pre-leukemia
- (2016) Noemi A. Zambetti et al. Cell Stem Cell
- Clonal Hematopoiesis of Indeterminate Potential
- (2016) Michael Heuser et al. Deutsches Arzteblatt International
- p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status
- (2016) A Quintás-Cardama et al. LEUKEMIA
- Negative impact on clinical outcome of the mutational co-occurrence of SF3B1 and DNMT3A in refractory anemia with ring sideroblasts (RARS)
- (2016) Iván Martín et al. LEUKEMIA & LYMPHOMA
- DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells
- (2016) Xiaotian Zhang et al. NATURE GENETICS
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
- (2016) M M Patnaik et al. Blood Cancer Journal
- CALR, JAK2, and MPL Mutation Profiles in Patients With Four Different Subtypes of Myeloproliferative Neoplasms
- (2015) Seon Young Kim et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Regulation of the Epigenome by Vitamin C
- (2015) Juan I. Young et al. Annual Review of Nutrition
- Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression
- (2015) C. A. Cargo et al. BLOOD
- MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance
- (2015) B. Kwok et al. BLOOD
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
- (2015) D. P. Steensma et al. BLOOD
- The inflammatory microenvironment in MDS
- (2015) Lili Yang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- The Methylcytosine Dioxygenase Tet2 Promotes DNA Demethylation and Activation of Cytokine Gene Expression in T Cells
- (2015) Kenji Ichiyama et al. IMMUNITY
- Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
- (2015) I Gañán-Gómez et al. LEUKEMIA
- Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
- (2015) Qian Zhang et al. NATURE
- TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
- (2014) R. Bejar et al. BLOOD
- DNA Demethylation: Where Genetics Meets Epigenetics
- (2014) Xiaofei Zhang et al. CURRENT PHARMACEUTICAL DESIGN
- New answers to old questions from genome-wide maps of DNA methylation in hematopoietic cells
- (2014) Mira Jeong et al. EXPERIMENTAL HEMATOLOGY
- Intravenous Vitamin C and Cancer
- (2014) Heidi Fritz et al. INTEGRATIVE CANCER THERAPIES
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
- (2014) Liran I. Shlush et al. NATURE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome
- (2014) T-C Chen et al. Blood Cancer Journal
- Clinical and biological implications of driver mutations in myelodysplastic syndromes
- (2013) E. Papaemmanuil et al. BLOOD
- Crystal Structure of TET2-DNA Complex: Insight into TET-Mediated 5mC Oxidation
- (2013) Lulu Hu et al. CELL
- Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms
- (2013) F Traina et al. LEUKEMIA
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- (2013) T Haferlach et al. LEUKEMIA
- Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells
- (2013) Kathryn Blaschke et al. NATURE
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
- (2013) W. W. Pang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia
- (2012) M. Jan et al. Science Translational Medicine
- Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
- (2012) David P. Steensma Current Hematologic Malignancy Reports
- Gene mutation and AML pathogenesis
- (2011) H. Dombret BLOOD
- DNA Methylation and Demethylation in Mammals
- (2011) Zhao-xia Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance
- (2011) V Grossmann et al. LEUKEMIA
- Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms
- (2010) F. X. Schaub et al. BLOOD
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
- (2009) O. Abdel-Wahab et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- Acquired mutations in TET2 are common in myelodysplastic syndromes
- (2009) Saskia M C Langemeijer et al. NATURE GENETICS
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
- (2009) Elaine R. Mardis et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started